Romark Laboratories, L.C. Initiates Phase 3 Trial of New Influenza Drug
4/18/2013 10:29:26 AM
More...
|
Romark Laboratories, L.C. Gets $44 Million Contract for Flu Treatment
3/1/2013 9:35:38 AM
More...
|
Romark Laboratories, L.C. Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011
10/21/2011 12:42:57 PM
More...
|
Romark Laboratories, L.C. Announces Data Presented at AASLD Meeting 2010
11/1/2010 7:59:14 AM
More...
|
Intercell AG and Romark Laboratories, L.C. Join Forces in Combining Therapies Against Hepatitis C
10/21/2010 9:09:57 AM
More...
|
Romark Laboratories, L.C. Announces Final Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C
5/5/2010 9:11:06 AM
More...
|
Romark Laboratories, L.C. Announces Data From Clinical Trial of Nitazoxanide in Treatment-Naive Patients With Genotype 1 Chronic Hepatitis C
4/15/2010 11:58:06 AM
More...
|
Romark Laboratories, L.C. Initiates Clinical Trial of Alinia for Treatment of Influenza New Class of Anti-Influenza Drugs with Unique Mechanism of Action Targets
2/1/2010 11:29:48 AM
More...
|
Romark Laboratories, L.C. Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology
3/2/2009 11:50:22 AM
More...
|
Romark Laboratories, L.C. and Chugai Pharmaceutical Co., Ltd. (Japan) Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
2/18/2009 8:20:55 AM
More...
|
|